Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Domenico Alvaro

Showing results (1-10 of 240) with videos related to

Pageof 24
Sort By:
Gut|November 10, 2011
Progranulin and cholangiocarcinoma: another bad boy on the block!Domenico Alvaro
Current Opinion in Gastroenterology|April 28, 2009
Serum and bile biomarkers for cholangiocarcinomaDomenico Alvaro
Hepatology (Baltimore, Md.)|June 13, 2017
The challenge of cholangiocarcinoma diagnosis: The turning point is in extracellular vesicles?Domenico Alvaro
Gastroenterology|March 30, 2017
Gallstones: Bad Company for the Steatotic LiverDomenico Alvaro
Hepatology (Baltimore, Md.)|March 15, 2016
Liver Capsule: Biliary Tree Stem Cell SubpopulationsDomenico Alvaro, Eugenio Gaudio
Hepatology (Baltimore, Md.)|April 26, 2012
The prognosis of perihilar cholangiocarcinoma after radical treatmentsLuca Fabris, Domenico Alvaro
Molecular Cancer Therapeutics|October 28, 2010
Ascofuranone: a possible therapeutic tool for autosomal dominant polycystic kidney disease?Vincenzo Cardinale, Domenico Alvaro
Gastroenterology|July 31, 2014
PTPN3 mutations and HBV may exert synergistic effects in the origin of the intrahepatic cholangiocarcinomaVincenzo Cardinale, Domenico Alvaro
World Journal of Gastrointestinal Oncology|December 17, 2010
New insights on cholangiocarcinomaManuela Gatto, Domenico Alvaro
Gastroenterology|January 28, 2012
Environmental contribution to pathogenesis of cyst formation in autosomal-dominant polycystic liver diseasesVincenzo Cardinale, Domenico Alvaro
Pageof 24

Showing results (1-10 of 240) with videos related to

Sort By:
Pageof 24
Gut|November 10, 2011
Progranulin and cholangiocarcinoma: another bad boy on the block!Domenico Alvaro
Current Opinion in Gastroenterology|April 28, 2009
Serum and bile biomarkers for cholangiocarcinomaDomenico Alvaro
Hepatology (Baltimore, Md.)|June 13, 2017
The challenge of cholangiocarcinoma diagnosis: The turning point is in extracellular vesicles?Domenico Alvaro
Gastroenterology|March 30, 2017
Gallstones: Bad Company for the Steatotic LiverDomenico Alvaro
Hepatology (Baltimore, Md.)|March 15, 2016
Liver Capsule: Biliary Tree Stem Cell SubpopulationsDomenico Alvaro, Eugenio Gaudio
Hepatology (Baltimore, Md.)|April 26, 2012
The prognosis of perihilar cholangiocarcinoma after radical treatmentsLuca Fabris, Domenico Alvaro
Molecular Cancer Therapeutics|October 28, 2010
Ascofuranone: a possible therapeutic tool for autosomal dominant polycystic kidney disease?Vincenzo Cardinale, Domenico Alvaro
Gastroenterology|July 31, 2014
PTPN3 mutations and HBV may exert synergistic effects in the origin of the intrahepatic cholangiocarcinomaVincenzo Cardinale, Domenico Alvaro
World Journal of Gastrointestinal Oncology|December 17, 2010
New insights on cholangiocarcinomaManuela Gatto, Domenico Alvaro
Gastroenterology|January 28, 2012
Environmental contribution to pathogenesis of cyst formation in autosomal-dominant polycystic liver diseasesVincenzo Cardinale, Domenico Alvaro
Pageof 24